Enfermedades retinianas y nuevas terapias
Universidad de Castilla-La Mancha
Ciudad Real, EspañaPublications in collaboration with researchers from Universidad de Castilla-La Mancha (10)
2023
-
Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study
International Ophthalmology, Vol. 43, Núm. 12, pp. 4639-4649
2020
-
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study
PharmacoEconomics - Open, Vol. 4, Núm. 4, pp. 615-624
-
Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients
PloS one, Vol. 15, Núm. 7, pp. e0236071
2019
-
Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN)
Progress in Retinal and Eye Research, Vol. 69, pp. 80-115
2018
-
Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants
Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72
2017
-
Early and intermediate age-related macular degeneration: Update and clinical review
Clinical Interventions in Aging, Vol. 12, pp. 1579-1587
2016
2015
-
Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome
Retina, Vol. 35, Núm. 12, pp. 2450-2456
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807
2010
-
Prevalence and causes of bilateral blindness and visual impairment among institutionalized elderly people in Pamplona, Spain
European Journal of Ophthalmology, Vol. 20, Núm. 2, pp. 442-450